October is Down Syndrome Awareness Month. It should be: Down Syndrome is at the center of a critical human-rights issue.
Many recent headlines concerning Down have extolled the “life-saving” advantages of a new blood test, administered in the first trimester of pregnancy, which can determine, with high accuracy, if an unborn child had the syndrome. The test, MaterniT21, will eliminate the miscarriage risk of chorionic villus sampling and amniocentesis, both invasive tests, and is far more reliable than current early blood tests.
But it is not a life-saving discovery for everyone. The fact is: 92% of mothers who discover that their unborn child has Down syndrome choose abortion....READ MORE